News
Ironwood Pharmaceuticals (IRWD) is undergoing a challenging transition with LINZESS but has promising growth potential with ...
Repligen (RGEN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback